HydraSpecma A/S financials
HydraSpecma A/S
5493003X6V92B0BSLH27 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €3.19B | €3.03B |
| Cost of sales | €2.34B | €2.25B |
| Gross profit | €854.1M | €783.1M |
| Other income | €15.4M | €2.6M |
| Distribution costs | €448.9M | €418.1M |
| Administrative expenses | €170.4M | €164.8M |
| Operating profit (EBIT) | €250.2M | €202.8M |
| Finance costs | €72.3M | €74.7M |
| Profit before tax | €184.5M | €136.1M |
| Income tax expense | €42.4M | €38.0M |
| Profit for the year | €142.1M | €98.1M |
| — attributable to owners | €92.4M | €58.8M |
| — attributable to NCI | -€246.0K | -€671.0K |
| Total comprehensive income | €168.8M | €81.5M |
| Cash flow statement | ||
| Cash generated from operations | €386.7M | €389.5M |
| Net cash from operating activities | €289.9M | €286.9M |
| Income taxes paid | €50.6M | €42.9M |
| Net cash from investing activities | €2.8M | -€89.2M |
| Purchase of PP&E (capex) | €34.1M | €76.0M |
| Purchase of intangibles | €6.9M | €8.5M |
| Net cash from financing activities | -€262.9M | -€172.7M |
| Dividends paid | €40.0M | €25.0M |
| Net change in cash | €29.8M | €25.1M |
| Balance sheet | ||
| Total assets | €2.84B | €2.75B |
| Non-current assets | €1.16B | €1.22B |
| Property, plant & equipment | €474.2M | €510.0M |
| Right-of-use assets | €107.1M | €118.4M |
| Intangible assets & goodwill | €557.2M | €570.0M |
| Current assets | €1.68B | €1.53B |
| Inventories | €678.2M | €649.2M |
| Trade & other receivables | €852.9M | €767.9M |
| Cash & equivalents | €123.3M | €101.4M |
| Total equity | €1.17B | €1.04B |
| — attributable to owners | €1.17B | €1.04B |
| Non-controlling interests | -€1.0M | -€763.0K |
| Non-current liabilities | €420.7M | €427.3M |
| Current liabilities | €1.25B | €1.28B |
| Current portion of long-term borrowings | €45.1M | €45.2M |
| Trade & other payables | €556.1M | €500.6M |
| Deferred tax liabilities | €82.8M | €82.0M |
| Derived metrics | ||
| Free cash flow | €255.9M | €211.0M |
| Operating margin | 7.8% | 6.7% |
| Net margin | 4.5% | 3.2% |
| Return on equity | 12.2% | 9.5% |
| Cash conversion ratio | 2.04× | 2.92× |
| Capex coverage | 8.51× | 3.78× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €138.8M | €135.8M |
| Adjustments For Finance Costs | €72.3M | €74.7M |
| Adjustments For Finance Income | €6.0M | €8.2M |
| Adjustments For Provisions | €18.9M | €3.4M |
| Adjustments For Undistributed Profits of Associates | €577.0K | -€135.0K |
| Brand Names | €0 | €5.1M |
| Cash Flows From Used In Increase Decrease In Current Borrowings | €269.0K | -€1.2M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €395.0M | €365.2M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €2.1M |
| Changes In Equity | -€40.0M | -€25.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | -€246.0K | -€671.0K |
| Comprehensive Income Attributable To Owners of Parent | €169.0M | €82.2M |
| Construction In Progress | €12.2M | €13.3M |
| Current Provisions | €28.5M | €16.5M |
| Current Tax Assets Current | €21.1M | €9.7M |
| Current Tax Liabilities Current | €20.2M | €11.3M |
| Deferred Tax Assets | €7.8M | €4.0M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | €50.0M | €40.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€7.9M | €2.4M |
| Equity and Liabilities | €2.84B | €2.75B |
| Finance Income | €6.0M | €8.2M |
| Fixtures and Fittings | €33.4M | €40.2M |
| Gains Losses On Cash Flow Hedges Before Tax | -€187.0K | -€856.0K |
| Income Tax Relating To Components of Other Comprehensive Income | -€41.0K | -€188.0K |
| Increase Decrease In Working Capital | €8.3M | -€24.3M |
| Increase Decrease Through Other Contributions By Owners | — | -€25.0M |
| Increase Decrease Through Transfers and Other Changes Equity | — | -€3.9M |
| Intangible Assets Under Development | €8.6M | €11.2M |
| Interest Paid Classified As Operating Activities | €48.6M | €63.1M |
| Interest Received Classified As Operating Activities | €2.5M | €3.5M |
| Investments In Associates Accounted For Using Equity Method | €10.9M | €10.9M |
| Issued Capital | €30.0M | €30.0M |
| Land and Buildings | €319.8M | €350.9M |
| Liabilities | €1.67B | €1.71B |
| Machinery | €108.7M | €105.6M |
| Noncurrent Provisions | €17.3M | €9.7M |
| Noncurrent Receivables | €5.5M | €6.2M |
| Other Adjustments For Noncash Items | -€12.9M | €23.3M |
| Other Comprehensive Income | €26.7M | -€16.6M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | €27.4M | -€11.6M |
| Other Expense By Function | €22.0K | €85.0K |
| Other Noncurrent Assets | €131.4M | €139.6M |
| Payments From Changes In Ownership Interests In Subsidiaries | €0 | €3.9M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €43.7M | €1.3M |
| Repayments of Noncurrent Borrowings | €47.1M | €49.9M |
| Reserve of Cash Flow Hedges | -€589.0K | -€443.0K |
| Reserve of Exchange Differences On Translation | -€82.2M | -€109.0M |
| Retained Earnings | €1.17B | €1.08B |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Before Tax | -€565.0K | -€457.0K |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €577.0K | -€135.0K |
Every line item above is a fact tagged in HydraSpecma A/S's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.